Apex Biotechnology

Apex Biotechnology Dividend Coverage

The Dividend Coverage Ratio of Apex Biotechnology (1733.TW) as of Nov 22, 2026 is 1.36. In the previous year, Dividend Coverage Ratio was 1.16 — a change of 16.85% (higher).

Dividend Coverage

1.36

YoY

16.85%

Last updated:

Dividend Coverage Ratio of Apex Biotechnology is 2025 1.36 . Dividend Coverage Ratio of Apex Biotechnology was 2024 1.16 . It decreases by 16.85% higher compared to the previous year.

The Apex Biotechnology Dividend Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend Coverage
Date
Dividend Coverage
Jan 1, 2018
1.27 TWD
Jan 1, 2019
1.37 TWD
Jan 1, 2020
0.85 TWD
Jan 1, 2021
2.30 TWD
Jan 1, 2022
1.40 TWD
Jan 1, 2023
0.83 TWD
Jan 1, 2024
1.16 TWD
Jan 1, 2025
1.36 TWD
The Apex Biotechnology Dividend Coverage history
YEARDividend CoverageYoY
1.36+16.85%
1.16+40.32%
0.83-40.86%
1.40-39.08%
2.30+169.31%
0.85-37.93%
1.37+8.06%
1.27-52.22%
2.66+23,422.29%
0.01-98.94%
1.07+27.84%
0.84—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Apex Biotechnology Stock analysis

What does Apex Biotechnology do? Apex Biotechnology Corp is a Taiwan-based company specializing in the development of innovative biotechnology products. The company was founded in 2002 and offers a wide range of products and services to its customers. Apex Biotechnology Corp began with the production of specialty chemicals and enzymes for research and development purposes. Over the years, the company has expanded its business and focused on the development of diagnostic products, dietary supplements, and pharmaceutical products. The company's business model focuses on the development and marketing of biotechnology products. Apex Biotechnology Corp has established advanced research centers and works closely with research institutions and pharmaceutical companies worldwide to develop innovative solutions. The company operates in various sectors, including diagnostics, dietary supplements, and pharmaceuticals. It offers a diverse range of products, including enzyme immunoassays, lateral flow tests, dietary supplements, and pharmaceuticals. Apex Biotechnology Corp has built strong relationships with research institutions and pharmaceutical companies and has successfully marketed its products internationally. Apex Biotechnology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Apex Biotechnology stock

Dividend Coverage Ratio of Apex Biotechnology is 1.36 in 2025.

Dividend Coverage Ratio of Apex Biotechnology changed from 1.16 to 1.36, representing a 16.85% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio Apex Biotechnology since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's Apex Biotechnology historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Apex Biotechnology

All Key Metrics — Apex Biotechnology